PP_1170x120_10-25-21

Sorilux Foam

Mayne Pharma releases Fabior, Sorilux foam

Mayne Pharma releases Fabior, Sorilux foam

GREENVILLE, N.C. — Mayne Pharma Inc. has rolled out Fabior Foam 0.1%, an acne treatment, and Sorilux Foam 0.005%, a psoriasis treatment, in the United States. Launched by the Mayne Pharma Specialty Brands division, Fabior and Sorilux foam previously were marketed by GlaxoSmithKline. Mayne acquired the two products in August 2016. Mayne said Fabior and